Finland· FI-REL-REL42396

Noroseal

A muut vetimien ja utareiden hoitoon tarkoitetut valmisteet product containing bismuth subnitrate, registered in Finland by Norbrook Laboratories (Ireland) Limited. The same ATC class is registered in 2 of our 19 countries.

ATC QG52X

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedNorosealATCQG52XREGISTER NO.FI-REL-REL42396PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Bismuth subnitrate is registered in 2 of 19 countries.

Countries holding a registration under ATC QG52X (muut vetimien ja utareiden hoitoon tarkoitetut valmisteet), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 1 of them publish a price we can compare per daily dose

Bismuth subnitrate · ATC QG52X

2 / 19 countries

  • Denmark
  • Finlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Bismuth subnitrate
Manufacturer
Norbrook Laboratories (Ireland) Limited
Country
Finland (FI)
ATC code
QG52X
ATC class
Muut vetimien ja utareiden hoitoon tarkoitetut valmisteet
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Bismuth subnitrate in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All bismuth subnitrate products

Authorised across Europe · EMA

The same active substance is authorised in 1 EEA country. Names it is sold under:

  • France · Bismuth Granions

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b67fcf6e-2686-47ea-9e5f-b53e0da18710
GET /v1/drugs/b67fcf6e-2686-47ea-9e5f-b53e0da18710?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": null,
  "form": "intramammaarisuspensio",
  "route": "Maitorauhaseen",
  "ddd_unit": null,
  "strength": "2.6 g",
  "atc_label": "Muut vetimien ja utareiden hoitoon tarkoitetut valmisteet",
  "ma_number": "30944",
  "auth_status": "Myyntilupa myönnetty",
  "eu_ma_number": null,
  "fimea_rel_id": "REL42396",
  "authorised_at": "2014-01-09"
}

See everything about bismuth subnitrate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.